(Q39361617)

11 September 2017

title

Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference (English)

1 reference

11 September 2017

Julio Pascual

1

1 reference

11 September 2017

Carlos García-Moncó

2

1 reference

11 September 2017

Carles Roig

3

1 reference

11 September 2017

Antonio Yusta Izquierdo

4

1 reference

11 September 2017

Arturo López-Gil

5

1 reference

11 September 2017

eMAX Study Group

6

1 reference

11 September 2017

publication date

1 October 2005

1 reference

11 September 2017

1 reference

11 September 2017

volume

45

1 reference

11 September 2017

issue

9

1 reference

11 September 2017

page(s)

1140-1150

1 reference

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Migraine--current understanding and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Migraine in the United States: epidemiology and patterns of health care use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Determinants of migraine-specific quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Migraine therapy: development and testing of a patient preference questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

The global burden of disease study: implications for neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Migraine and chronic daily headache management: a qualitative study of patients' perceptions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Evaluation of migraineurs' preferences for naratriptan over conventional first-line agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

What do patients with migraine want from acute migraine treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Determinants of patient satisfaction with migraine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine. Rizatriptan Multicenter Study Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Real-world experiences in migraine therapy with rizatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.00237.X

10.1111/J.1526-4610.2005.00237.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference